Immunic, Inc.
IMUX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001280776
No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Immunic, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 1 | 73 | −8 |
| Shares | 17.6M | 2.26K | 18.3M | +658.9K (+3.7%) |
| Value | $199.0M | $26.0K | $63.4M | −$135.6M (−68.1%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Immunic, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,104,241 | $3.83M | 3.26% |
| Adage Capital Partners GP, L.L.C. | 600,900 | $2.08M | 0.00% |
| UBS Oconnor LLC | 232,591 | $807.0K | 0.01% |
| Ergoteles LLC | 90,400 | $314.0K | 0.01% |
| Acadian Asset Management LLC | 77,740 | $270.0K | 0.00% |
| Ikarian Capital, LLC | 61,500 | $214.0K | 0.09% |
| Renaissance Technologies LLC | 29,200 | $101.0K | 0.00% |
| Simplex Trading, LLC | 25,874 | $89.0K | 0.00% |
| XTX Topco Ltd | 19,972 | $69.0K | 0.03% |
| Boothbay Fund Management, LLC | 17,831 | $62.0K | 0.00% |
| Qube Research & Technologies Ltd | 15,710 | $55.0K | 0.00% |
| Engineers Gate Manager LP | 13,640 | $47.0K | 0.00% |
| Delphia (USA) Inc. | 13,181 | $46.0K | 0.03% |
| Corton Capital Inc. | 12,142 | $42.0K | 0.04% |
| LMR Partners LLP | 10,000 | $35.0K | 0.00% |
| Credit Suisse AG | 10 | $0 | 0.00% |
| CWM, LLC | 12 | $0 | 0.00% |
Sold out (25)
Institutions that held Immunic, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (1)
Institutions that held Immunic, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,264 | $26.0K |